Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

T-SPOT.TB for Detection of Tuberculosis Infection among Hematological Malignancy Patients and Hematopoietic Stem Cell Transplant Recipients

  • Qin, Li-Li (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Wang, Qin-Rong (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Wang, Qian (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Yao, Hong (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Wen, Li-Jun (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Wu, Li-Li (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Ping, Na-Na (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Xie, Jun-Dan (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Chen, Mei-Yu (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University) ;
  • Chen, Su-Ning (Leukemia Research Division, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University)
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The diagnosis of latent Mycobacterium tuberculosis infection (LTBI) is recommended in hematological malignancy patients and before hematopoietic stem cell transplantation (Guidelines for the prevention and management of infectious complications of solid organ transplantation, 2004). Compared to traditional methods such as tuberculin skin test (TST), T-SPOT.TB has been shown to be more specific. In the present study we enrolled 536 patients for whom T-SPOT.TB was performed, among which 295 patients also received the TST test. The agreement (79%) between T-SPOT.TB and TST was poor (x=0.274, P<0.001). The patients with positive T-SPOT.TB results numbered 62 (11.6%), in which only 20 (48.8%) of the 41 receiving the TST test had positive results. A majority of the patients with T-SPOT.TB positive results had some other evidence ofTB, such as TB history, clinical symptoms and an abnormal chest CT scan. Active TB was found in 9 patients, in which 2 had negative TST results. We followed up the patients and no one developed active TB. Our study suggested that the T-SPOT.TB may be more useful for screening LTBI and active TB in hematological malignancy patients and hematopoietic stem cell transplant recipients than the TST test.

Keywords

References

  1. Andersen P, Munk ME, Pollock JM, et al (2000). Specific immune-based diagnosis of tuberculosis. Lancet, 356, 1099-104. https://doi.org/10.1016/S0140-6736(00)02742-2
  2. Benito N, Sued O, Moreno A, et al (2002). Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation, 74, 1381-6. https://doi.org/10.1097/00007890-200211270-00006
  3. Dolin PJ, Raviglione MC, Kochi A (1994). Global tuberculosis incidence and mortality during 1990-2000. Bull WHO, 72, 213-20.
  4. Guidelines for the prevention and management of infectious complications of solid organ transplantation (2004). Am J Transplant, 4, 164-66. https://doi.org/10.1111/j.1600-6135.2004.00738.x
  5. Huebner RE, Schein MF, Bass JB, Jr (1993). The tuberculin skin test. Clin Infect Dis, 17, 968-75. https://doi.org/10.1093/clinids/17.6.968
  6. Lee DG, Kim SH, Kim SY, et al (2011). Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med, 26, 220-52. https://doi.org/10.3904/kjim.2011.26.2.220
  7. Mazurek GH, Jereb J, Vernon A, et al (2010). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep, 59, 1-25.
  8. Menzies D, Pai M, Comstock G (2007). Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med, 146, 340-54. https://doi.org/10.7326/0003-4819-146-5-200703060-00006
  9. Moon SM, Lee SO, Choi SH, et al (2013). Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis, 15, 104-9. https://doi.org/10.1111/j.1399-3062.2012.00765.x
  10. Munoz P, Rodríguez C, Bouza E (2005). Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis, 40, 581-7. https://doi.org/10.1086/427692
  11. Pai M, Riley LW, Colford JM Jr (2004). Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis, 4, 761-76. https://doi.org/10.1016/S1473-3099(04)01206-X
  12. Pai M, Zwerling A, Menzies D (2008). Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med, 149, 177-84. https://doi.org/10.7326/0003-4819-149-3-200808050-00241
  13. Piana F, Codecasa LR, Cavallerio P, et al (2006). Use of a T-cellbased test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J, 28, 31-4. https://doi.org/10.1183/09031936.06.00110205
  14. Santín Cerezales M, Benítez JD (2011). Diagnosis of tuberculosis infection using interferon-$\gamma$-based assays. Enferm Infecc Microbiol Clin, 29, 26-33.
  15. Thijsen SF, Bossink AW (2009). Interferon gamma release assays for diagnosing active and latent tuberculosis. Expert Opin Med Diagn, 3, 303-12. https://doi.org/10.1517/17530050902758738

Cited by

  1. Elevated Serum Ferritin Levels in Patients with Hematologic Malignancies vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6099
  2. T Cells after Allogeneic Hematopoietic Stem Cell Transplantation and its Correlation with Invasive Fungal Infection in Patients with Hematological Malignancies vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3137
  3. Detecting latent tuberculosis in compromised patients vol.28, pp.3, 2015, https://doi.org/10.1097/QCO.0000000000000158
  4. Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries vol.8, pp.5, 2015, https://doi.org/10.1586/17474086.2015.1071186
  5. infection after hematopoietic stem cell transplantation in adults pp.09020063, 2018, https://doi.org/10.1111/ctr.13430